Laser peripheral iridotomy

1 paper2 findings

In silico1

Outcomes

1

Quality-adjusted life-years

upin silico1

1 study

Laser peripheral iridotomy improves quality-adjusted life-years in silico (13.54 vs 13.49 QALYs).
“the PACS with LPI resulted in a higher QALYs, totaling 13.54, compared to 13.49 QALYs in the NO LPI strategy.”
In silicoPACS30 years
Cost-effectiveness of laser peripheral iridotomy in the treatment of primary angle closure suspect in China: a Markov model
BMC health services research28 Apr 2026

Associations

1

Primary angle-closure glaucoma

downin silico1

1 study

Laser peripheral iridotomy lowers the risk of primary angle-closure glaucoma in silico (6.39% vs 12.19%).
“the avoided glaucoma rate was 6.39% for PACS with LPI over 30 years, significantly lower than the rate for the NO LPI strategy, which was 12.19%.”
In silicoPACS30 years
Cost-effectiveness of laser peripheral iridotomy in the treatment of primary angle closure suspect in China: a Markov model
BMC health services research28 Apr 2026

More on Primary angle-closure glaucoma

Latest

1 in 12 months

BMC Health Services Research29 Apr

Cost-effectiveness of laser peripheral iridotomy in the treatment of primary angle closure suspect in China: a Markov model

Computational studyInterventions